Jnba Financial Advisors Astrazeneca PLC Transaction History
Jnba Financial Advisors
- $1.11 Billion
- Q4 2025
A detailed history of Jnba Financial Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, Jnba Financial Advisors holds 481 shares of AZN stock, worth $43,001. This represents 0.0% of its overall portfolio holdings.
Number of Shares
481
Previous 341
41.06%
Holding current value
$43,001
Previous $26,000
65.38%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AZN
# of Institutions
1,545Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...